AIToday
AI in HealthcareAI Safety & AlignmentTHE DECODERPublished: Aug 13, 2026, 04:01 JST

AI breast cancer tools disappoint radiologists in real-world use

AI breast cancer tools disappoint radiologists in real-world use

3 Key Points

  1. What happened

    A survey of 215 breast imaging specialists found that about half already use FDA-approved AI tools for detecting breast cancer, and 11 percent plan to. However, the tools are delivering far fewer benefits than radiologists anticipated: only 35 percent report lower recall rates (though 59 percent expected this), 9 percent see fewer unnecessary biopsies (36 percent expected this), and 29 percent report less burnout (56 percent expected relief).

  2. Why it matters

    Radiologists view current AI mostly as a second opinion rather than a transformative tool. The gap between expectation and reality highlights a pattern where AI industry leaders made bold predictions about job displacement—a phenomenon UC San Diego Health's Joud Almogati's research now documents in practice. Nvidia CEO Jensen Huang has characterized such predictions as a "God complex" among AI commentators.

  3. What to watch

    Costs and lack of institutional support are cited as the biggest barriers to broader adoption. The survey suggests that for AI tools to meet radiologists' needs, either the technology must improve significantly or institutions must address structural obstacles to integration.

Not sure about something? Ask the AI

Questions and answers are published on this page.

Summaries like this, in your inbox every morning.

Context & Analysis

The disconnect between radiologists' expectations and the tools' actual performance reflects a broader pattern in AI adoption. Lead author Joud Almogati's research, published in Clinical Imaging, documents what happens when industry hype meets clinical reality. Radiologists have come to view current AI tools primarily as a second opinion rather than as a means of significant transformation—a far cry from the transformative role the technology was marketed to play.

This gap has historical roots. About ten years ago, prominent AI researchers predicted that radiologists would soon be obsolete, a claim that has resurfaced in recent discussions about AI and knowledge work more broadly. However, Nvidia CEO Jensen Huang has characterized such dire predictions as a "God complex" among AI commentators, suggesting that the industry may have systematized overstatement about labor displacement. The survey results support a more measured view: the tools help, but they fall short of the promises made when they were introduced.

FAQ
What percentage of radiologists currently use FDA-approved AI tools for breast cancer detection?
About half of the 215 Society of Breast Imaging members surveyed already use FDA-approved AI tools, and 11 percent plan to.
What specific benefits did radiologists expect from AI breast cancer tools, and what did they actually experience?
Radiologists expected 59 percent to see lower recall rates, but only 35 percent reported this; 36 percent expected fewer unnecessary biopsies, but only 9 percent saw this; and 56 percent expected less burnout, but only 29 percent reported relief.
What are the main barriers to wider adoption of AI tools in breast imaging?
Costs and lack of institutional support remain the biggest barriers, according to the survey.

AI news that matters for your work, delivered every morning.

Pick your industry and the AI tools you use, and get news related to your work every day.

Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →

Ask AI

Ask AI anything about this article. The AI reads this article, earlier AIToday articles, and Wikipedia, and cites its sources. Q&As are published on this page for other readers too.

Questions and answers are published on this page.

Related Articles

Next articleGoogle DeepMind's top exec rose from Indiana cornfields to lead AI readiness